Smarter. Faster. Intuitive.
Meet Aika
The new standard for clinical trials
Aika is the first AI-native platform for clinical trials, built to streamline protocol design, feasibility, and regulatory planning in one intuitive workspace. It helps clinical teams accelerate trial setup, reduce risk, and bring treatments to patients faster.
Features
Testimonials
Trusted by Leaders. Backed by Science.
Trained on 560,000+ clinical trials.
“Biorce is exactly the kind of pioneering company we’re here to back. They’re combining deep sector expertise with cutting-edge AI to solve what truly matters. Their platform has the potential to radically reduce both the time and cost of bringing new treatments to market, unlocking huge value for pharma and, more importantly, faster access to life-saving therapies for patients.”
Tove Larsson
General Partner | Norrsken VC
Used across US, EU & APAC by global clinical trial teams.
"The expansive potential of Jarvis hints at a wealth of untapped applications beyond drugs development; it opens the door to evolutionary possibilities that could help redefine efficiency and precision in the broader medical field"
Ricardo Matias
CRIO | Co-Founder of Kinetikos
Built by former CRO, clinicians, regulatory, and AI leaders.
$5M invested by Norrsken, Europe’s leading impact VC to reinvent clinical trials.
"I think this is a fantastic tool for clinical trialists that will not only save time but could potentially reduce the number of avoidable protocol amendments, saving costs and enhancing confidence in evaluation of the study objectives"
Laurence Skillern